Long-term  safety of facilitated subcutaneous immunoglobulin treatment in pregnant women with primary immunodeficiency diseases: results from a registry study

Immunotherapy, Ahead of Print.

Source: Immunotherapy - April 21, 2022 Category: Allergy & Immunology Authors: Michael Borte Stefan Raffac Martin Hrubi ško Karina Jahnz-Rozyk Enrique Garcia Barbara McCoy Shailesh Chavan Andras Nagy Leman Yel Source Type: research